Could paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?

American Journal of Cardiology

Volumn 106, Issue 9, 2010, Pages 1367-1368

  Brilakis, Emmanouil S ^a   Banerjee, Subhash ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; NOTE; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT LESION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

EID: 77958543620     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.008     Document Type: Letter

References (5)

1. M.S. Lee, P.P. Hu, J. Aragon, A.P. Shah, J. Oyama, J. Dhoot, Z. Iqbal, N. Jones, W. Penny, J. Tobis, E. Mahmud, and W. French Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a Multicenter Southern California Registry) Am J Cardiol 106 2010 337 341
2. P. Vermeersch, P. Agostoni, S. Verheye, P. Van den Heuvel, C. Convens, F. Van den Branden, and G. Van Langenhove Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial J Am Coll Cardiol 50 2007 261 267
3. E.S. Brilakis, C. Lichtenwalter, J.A. de Lemos, M. Roesle, O. Obel, D. Haagen, B. Saeed, C. Gadiparthi, J.K. Bissett, R. Sachdeva, V.V. Voudris, P. Karyofillis, B. Kar, J. Rossen, P. Fasseas, P. Berger, and S. Banerjee A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial J Am Coll Cardiol 53 2009 919 928
4. J. Rodes-Cabau, O.F. Bertrand, E. Larose, J.-P. Dery, S. Rinfret, R. Bagur, G. Proulx, C.M. Nguyen, M. Cote, M.-C. Landcop, J.-R. Boudreault, J. Rouleau, L. Roy, O. Gleeton, G. Barbeau, B. Noel, J. Courtis, G.R. Dagenais, J.-P. Despres, and R. DeLarochelliere Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions The Moderate Vein Graft Lesion Stenting With the Taxus Stent and Intravascular Ultrasound (VELETI) pilot trial Circulation 120 2009 1978 1986
5. E.S. Brilakis, J.M. Lasala, D.A. Cox, P.B. Berger, T.S. Bowman, R.M. Starzyk, and K.D. Dawkins Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program J Am Coll Cardiol Intv 3 2010 742 750